EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS

Dana Strouhalova iD, Dana Macejova iD, Julius Brtko iD, Janette Bobalova iD

Journal of Mass Spectrometry · 2026

DOI: 10.1002/jms.70090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2026. Verfasst von Dana Strouhalova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Analytical Chemistry of the CAS, Brno, Czech Republic. Hauptthemen laut MEDLINE: Trialkyltin Compounds, Heat-Shock Proteins, Propionates, Retinoid X Receptors. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: institutional support, Agentúra na Podporu Výskumu a Vývoja, Vedecká Grantová Agentúra MŠVVaM SR a SAV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organotin (IV) compounds are known to induce apoptosis via the intrinsic mitochondrial pathway, which is a key mechanism of effective anticancer therapy. Their ability to selectively promote apoptotic cell death highlights their potential as chemotherapeutic agents. In this study, the in vitro effects of two triorganotin compounds, tributyltin propionate and tributyltin salicylate, on the human breast cancer cell line MDA‐MB‐231 were evaluated. In addition to their proven antitumor activity, these compounds may act as synthetic ligands for nuclear retinoid X receptors. Protein expression profiles were examined using gel electrophoresis and MALDI‐TOF mass spectrometry, with a particular focus on heat shock proteins (HSPs), which are commonly overexpressed in cancer cells and contribute to tumor progression and therapeutic resistance. Both triorganotin derivatives significantly reduced HSP expression, suggesting that HSPs could be a promising target in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trialkyltin CompoundsHeat-Shock ProteinsPropionatesRetinoid X ReceptorsAntineoplastic AgentsSalicylatesHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass SpectrometryBreast NeoplasmsMDA-MB-231 CellsFemaleLigands

Stichwörter der Autor:innen

MALDI MS/MSbreast cancerheat shock proteins familyproteomictributyltin salicylate and tributyltin propionate

Substanzen

Trialkyltin CompoundstributyltinHeat-Shock ProteinsPropionatesRetinoid X ReceptorsLigandsAntineoplastic AgentsSalicylates

Autor:innen und Institutionen

  • Institute of Analytical Chemistry of the CAS, Brno, Czech Republic.
  • Institute of Experimental Endocrinology, Biomedical Research Center of the SlovakAcademy of Sciences, Bratislava, Slovak Republic.

ORCID-Profile: Dana Strouhalova, Dana Macejova, Julius Brtko, Janette Bobalova

Förderung

  • institutional support
  • Agentúra na Podporu Výskumu a Vývoja
  • Vedecká Grantová Agentúra MŠVVaM SR a SAV
  • Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Zitieren

APA

Strouhalova, D., Macejova, D., Brtko, J., & Bobalova, J. (2026). Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.70090

Vancouver

Strouhalova D, Macejova D, Brtko J, Bobalova J. Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS. Journal of Mass Spectrometry. 2026. doi:10.1002/jms.70090

BibTeX
@article{Strouhalova2026,
  author = {Strouhalova, Dana and Macejova, Dana and Brtko, Julius and Bobalova, Janette},
  title = {Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS},
  journal = {Journal of Mass Spectrometry},
  year = {2026},
  doi = {10.1002/jms.70090}
}
Kostenlos starten →